Christopher P Leamon is Chief Scientific Officer of Fusion Pharmaceuticals Inc.. Currently has a direct ownership of 0 shares of FUSN, which is worth approximately $0. The most recent transaction as insider was on Jun 04, 2024, when has been sold 11,957 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Christopher P Leamon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2024
SELL
Sale (or disposition) back to the issuer
-
11,957 Reduced 100.0%
0 Common Stock
Aug 31 2023
BUY
Grant, award, or other acquisition
-
11,957 Added 50.0%
11,957 Common Stock
CPL

Christopher P Leamon

Chief Scientific Officer
Boston, MA

Track Institutional and Insider Activities on FUSN

Follow Fusion Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FUSN shares.

Notify only if

Insider Trading

Get notified when an Fusion Pharmaceuticals Inc. insider buys or sells FUSN shares.

Notify only if

News

Receive news related to Fusion Pharmaceuticals Inc.

Track Activities on FUSN